RIG‐I activation enhances innate immune responses in the tumor microenvironment, boosting NK cell‐mediated cytotoxicity and the antigen‐presenting functions of macrophages and dendritic cells [20, 21]. This evidence concerns the gene RIGI and neoplasm.